WashU, MilliporeSigma sign collaboration agreement

A project that could help scientists identify novel ways to fight disease is one of the research efforts that will get a significant boost under a new collaboration agreement that Washington University in St. Louis has signed with leading science and technology company MilliporeSigma. The partnership builds on nearly a century of shared innovation and marks a significant expansion of research cooperation between the two organizations.

On July 24, the company signed a nonbinding memorandum of understanding with WashU. The agreement covers cooperative programs between MilliporeSigma and schools across WashU, including Arts & Sciences, the McKelvey School of Engineering and WashU Medicine.

“This agreement represents a new milestone in the shared history of WashU and MilliporeSigma,” Chancellor Andrew D. Martin said. “Collaboration is central to our university’s research and scientific success. Partnering with an industry leader like MilliporeSigma will expand our capacity to generate solutions to the world’s greatest challenges.”

“Academic-industry collaborations are more critical than ever in today’s dynamic scientific landscape,” said Jean-Charles Wirth, chief executive officer of MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. “Our partnership with WashU underscores MilliporeSigma’s commitment to empower the next generation of scientists driving progress in health care and the life sciences. By combining WashU’s world-class research capabilities with our advanced technologies and industry expertise, we can fuel innovation with lasting impact.”

Read the full story here.

Back to News